Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-25 @ 3:57 AM
NCT ID:
NCT01867502
Eligibility Criteria:
Inclusion Criteria:
* Type 2 diabetes (fasting glucose ≥ 126 mg/dl or 7.0 mmol/l)(25);
* Recent HbA1C determination (between 7, 5 and 10%);
* Not involved in regular physical exercise;
* Older than 18 years;
* In use of Metformin.
Exclusion Criteria:
* Smoker and use of analgesic or anti-inflammatory drugs during the week of the study
* BMI \> 40 kg/m²;
* Proliferative retinopathy;
* Ischemic cardiomyopathy;
* Peripheral vascular disease;
* Blood Aspartate transaminase (AST) and Alanine transaminase (ALT) 2.5 times higher the normal concentration before screening visit
* Lactose intolerance;
* Renal insufficiency (creatinine clearance \<60ml/min);
* Blood pressure more than 180/100mmHg at rest (3 consecutive measures).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01867502
Study Brief:
Protocol Section:
NCT01867502